Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XNZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $32,500
Award facts
- Contract value 100% obligated
- $32,499.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $32.5K on July 22, 2025, for Stelara 90 mg/mL syringes. This firm fixed-price delivery order, which must be completed by August 12, 2025, was issued without a set-aside designation and is funded through the Defense or Civilian Medical Supply Chain agency. The contract represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500M vehicle valid through November 2026 that enables the issuance of delivery orders for comprehensive pharmaceutical and medical supply needs across Department of Defense healthcare facilities.
As a pharmaceutical wholesaler, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal agencies and military healthcare systems nationwide. The company has established itself as a key supplier in the federal pharmaceutical supply chain through consistent contract performance, with its contract portfolio demonstrating expertise in delivering specialized pharmaceutical products including biologics, oncology treatments, and injectable medications. This delivery order for Stelara, a biologic medication commonly used for autoimmune conditions, exemplifies the company's role in providing critical pharmaceutical products to support Department of Defense medical operations and readiness.
Quick answers
Who was awarded contract SPE2DX25F6XNZ?
SPE2DX25F6XNZ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 22, 2025.
How much is contract SPE2DX25F6XNZ worth?
The government has obligated $32,500 on SPE2DX25F6XNZ.
Is contract SPE2DX25F6XNZ an order under another contract?
Yes. SPE2DX25F6XNZ is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XNZ competed?
The extent of competition for SPE2DX25F6XNZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award